The research of Dr Arsenault’s team focuses on the impact of lifestyle, genetics and pharmacotherapy on lipoprotein metabolism, cardiometabolic risk and cardiovascular diseases such as calcific aortic valve stenosis. He has authored or co-authored more than 80 peer-reviewed scientific manuscripts in major medical, scientific and cardiology journals and now holds a junior scholar award from the Fonds de recherche du Québec: Santé. He has received several distinctions such as the Young Investigator Clinical Science Award of the European Society of Cardiology in 2011.